Primary Cells

Human Chronic Lymphoid Leukemia Peripheral Blood CD19+ B Cells (Relapsed/Refractory)

  • For research use only

Cat No.

ABC-TC3352

Product Type

Immune Cells

Cell Type

B Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Chronic Lymphoid Leukemia

Storage

Liquid Nitrogen

Utilize Human Chronic Lymphoid Leukemia Peripheral Blood CD19+ B Cells (Relapsed/Refractory) for drug screening and leukemia immunophenotyping.

Product Image

Description

Chronic Lymphoid Leukemia-PB-CD19+ B cells are positively isolated from Chronic Lymphoid Leukemia peripheral blood Mononuclear Cells, using a direct immunomagnetic CD19 MicroBeads labeling system. Chronic Lymphoid Leukemia-CD19+ B cells are available in untreated and relapsed/refractory stages.

Species

Human

Cat.No

ABC-TC3352

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

B Cell

Growth Mode

Suspension

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Chronic Lymphoid Leukemia

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Immune Cells

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Chronic Lymphoid Leukemia Peripheral Blood CD19+ B Cells (Relapsed/Refractory)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button